Telaprevir for Retreatment of HCV Infection

Stefan Zeuzem, Pietro Andreoné, Stanislas Pol, +22

New England Journal of Medicine

Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study

Eric Lawitz, Mark Sulkowski, Reem Ghalib, +19

The Lancet

HepatologyHepatitis CViral HepatitisAntiviral Drug DevelopmentAntiviral Therapy +7

Human Immunodeficiency Virus Type 1 in the Semen of Men Receiving Highly Active Antiretroviral Therapy

Hui Zhang, Geethanjali Dornadula, Maria Beumont, +4

New England Journal of Medicine

Telaprevir Alone or With Peginterferon and Ribavirin Reduces HCV RNA in Patients With Chronic Genotype 2 but Not Genotype 3 Infections

Graham R. Foster, Christophe Hézode, Jean–Pierre Bronowicki, +7

Gastroenterology

Genotype 3Viral PersistenceViral HepatitisTelaprevir AloneAntiviral Therapy +7

Evolution of Treatment-Emergent Resistant Variants in Telaprevir Phase 3 Clinical Trials

James C. Sullivan, Sandra De Meyer, Doug J. Bartels, +14

Clinical Infectious Diseases

Telaprevir Is Effective Given Every 8 or 12 Hours With Ribavirin and Peginterferon Alfa-2a or -2b to Patients With Chronic Hepatitis C

Patrick Marcellin, Xavier Forns, Tobias Goeser, +10

Gastroenterology

HepatologyHepatitis CViral HepatitisAntiviral Drug DevelopmentAntiviral Therapy +8

Virology analyses of HCV isolates from genotype 1-infected patients treated with simeprevir plus peginterferon/ribavirin in Phase IIb/III studies

Oliver Lenz, Thierry Verbinnen, Bart Fevery, +8

Journal of Hepatology

CD4 T Lymphocyte Count and the Radiographic Presentation of Pulmonary Tuberculosis

Mark D. Keiper, Maria Beumont, Ashraf A. Elshami, +2

CHEST Journal

Combination treatments including the small-interfering RNA JNJ-3989 induce rapid and sometimes prolonged viral responses in patients with CHB

Man‐Fung Yuen, Stephen Locarnini, Tien Huey Lim, +19

Journal of Hepatology

Hepatitis C Viral Evolution in Genotype 1 Treatment-Naïve and Treatment-Experienced Patients Receiving Telaprevir-Based Therapy in Clinical Trials

Tara L. Kieffer, Sandra De Meyer, Doug J. Bartels, +17

PLoS ONE